000 03738nlm1a2200337 4500
001 647981
005 20231030040821.0
035 _a(RuTPU)RU\TPU\network\13138
090 _a647981
100 _a20160429a2015 k y0engy50 ba
101 0 _aeng
135 _adrcn ---uucaa
181 0 _ai
182 0 _ab
200 1 _aInfluence of Antihypertensive Therapy on Cerebral Perfusion in Patients with Metabolic Syndrome: Relationship with Cognitive Function and 24-h Arterial Blood Pressure Monitoring
_fN. Yu. Efimova [et al.]
203 _aText
_celectronic
300 _aTitle screen
320 _a[References: 36 tit.]
330 _aAimsTo investigate the regional cerebral blood flow, cognitive function, and parameters of 24-h arterial blood pressure monitoring in patients with metabolic syndrome before and after combination antihypertensive therapy.MethodsThe study involved 54 patients with metabolic syndrome (MetS) investigated by brain single-photon emission computed tomography, 24-h blood pressure monitoring (ABPM), and comprehensive neuropsychological testing before and after 24 weeks of combination antihypertensive therapy.ResultsPatients with metabolic syndrome had significantly poorer regional cerebral blood flow compared with control group: by 7% (P = 0.003) in right anterior parietal cortex, by 6% (P = 0.028) in left anterior parietal cortex, by 8% (P = 0.007) in right superior frontal lobe, and by 10% (P = 0.00002) and 7% (P = 0.006) in right and left temporal brain regions, correspondingly. The results of neuropsychological testing showed 11% decrease in mentation (P = 0.002), and 19% (P = 0.011) and 20% (P = 0.009) decrease in immediate verbal and visual memory in patients with MetS as compared with control group. Relationships between the indices of ABPM, cerebral perfusion, and cognitive function were found. Data showed an improvement of regional cerebral blood flow, ABPM parameters, and indicators of cognitive functions after 6 months of antihypertensive therapy in patients with MetS.ConclusionThe study showed the presence of diffuse disturbances in cerebral perfusion is associated with cognitive disorders in patients with metabolic syndrome. Combination antihypertensive treatment exerts beneficial effects on the 24-h blood pressure profile, increases cerebral blood flow, and improves cognitive function in patients with MetS.
461 _tCardiovascular Therapeutics
463 _tVol. 33, iss. 4
_v[P. 209-215]
_d2015
610 1 _aэлектронный ресурс
610 1 _aтруды учёных ТПУ
701 1 _aEfimova
_bN. Yu.
_cspecialist in the field of medical technology
_claboratory assistant of Tomsk Polytechnic University, Doctor of medical science
_f1972-
_gNataliya Yurievna
_2stltpush
_3(RuTPU)RU\TPU\pers\34257
701 1 _aChernov
_bV. I.
_cspecialist in the field of medical technology
_clead engineer of Tomsk Polytechnic University, doctor of medical sciences
_f1962-
_gVladimir Ivanovich
_2stltpush
_3(RuTPU)RU\TPU\pers\34191
701 1 _aEfimova
_bI. Yu.
_gIrina Yurjevna
701 1 _aLishmanov
_bYu. B.
_cspecialist in the field of medical technology
_clead engineer aof Tomsk Polytechnic University, doctor of medical sciences
_f1951-
_gYury Borisovich
_2stltpush
_3(RuTPU)RU\TPU\pers\34200
712 0 2 _aНациональный исследовательский Томский политехнический университет (ТПУ)
_bФизико-технический институт (ФТИ)
_bЛаборатория № 31 ядерного реактора (Лаборатория № 31 ЯР)
_h6471
_2stltpush
_3(RuTPU)RU\TPU\col\20054
801 2 _aRU
_b63413507
_c20160429
_gRCR
856 4 _uhttp://dx.doi.org/10.1111/1755-5922.12136
942 _cCF